Page 82 - journal-8-23-Full
P. 82

74   «“√ “√°“√·æ∑¬ ¬“  ∑ – · ∑ ߬· °  ¬å∑“߇≈◊Õ°                           ªï∑’Ë 9©∫—∫∑’Ë 1 ¡°√“§¡ -  ‘ßÀ“§¡  2554
                                            ≈
               √  ° æ å· π
               √  °“ æ ¬å· π ∑¬· –° · ∑¬ ß ≈ °å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ° ° 
             «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬
             °“√μàÕμâ“π‚√§¿Ÿ¡‘·æâ®“°æ◊™«ß»å¢‘ß                       °“√»÷°…“Õß§åª√–°Õ∫∑“߇§¡’¢ÕßÀ≠â“≈‘Èπߟ (Hedyotis

              ÿ¿‘≠≠“ μ‘Ϋμ√–°Ÿ≈,  π—Ëπ »ÿ¿∏’√ °ÿ≈               corymbosa Lamk.) ‚¥¬π”¡“·¬°¥â«¬«‘∏’‚§√¡“‚∑°√“øï æ∫
             ¿“§«‘™“‡¿ —™‡«∑·≈–‡¿ —™æƒ°…»“ μ√å §≥–‡¿ —™»“ μ√å ¡À“«‘∑¬“≈—¬   “√ª√–°Õ∫ 7 ™π‘¥§◊Õ aurantiamide acetate (1), 3β-
              ß¢≈“π§√‘π∑√å                                      acetylaleuritolic acid (2), salicylic acid (3), b-sitosteryl-

             Journal of Ethnopharmacology 2007;109(3):535-8.    3-O-b-D-glucopyranoside (6),1,5-anhydroglucitol (7)
                 π”æ◊™„π«ß»å¢‘ß®”π«π 6 ™π‘¥ ‰¥â·°à ¢¡‘Èπ¢“« (Curcuma  ·≈– “√º ¡¢Õß 22,23-dihydrochondrillasterol (4) ·≈–
             mangga) ‡ª√“–ÀÕ¡ (Kaempferia galangal) °√–™“¬¥”    chondrillasterol (5)  “√ª√–°Õ∫ (1) ‡ªìπ “√‰¥‡ªª‰∑¥å∑’Ë

             (Kaempferia parviflora) ‰æ≈ (Zingiber cassumunar) ¢‘ß  ·¬°‰¥â§√—Èß·√°®“°æ◊™ °ÿ≈π’È °“√æ‘ Ÿ®πå‚§√ß √â“ߢÕß “√„™â
             (Zingiber officinale) ·≈–°√–∑◊Õ (Zingiber zerumbet) ‚¥¬  ‡∑§π‘§∑“ß ‡ª°‚∑√ ‚°ªï π” “√ °—¥·≈– “√∫√‘ ÿ∑∏‘Ï∑’Ë·¬°

             π”‡Àßâ“¢Õßæ◊™∑—Èß 6 ™π‘¥¡“ °—¥¥â«¬·Õ≈°ÕŒÕ≈å·≈–πÈ” √«¡  ‰¥â¡“∑¥ Õ∫§«“¡‡ªìπæ‘…μàÕ‡´≈≈å¡–‡√Áßæ∫«à“ “¡“√∂μàÕ
             ∑—ÈßπÈ”¡—πÀÕ¡√–‡À¬π”¡“∑¥ Õ∫°—∫‡´≈≈凿“–‡≈’È¬ß™π‘¥ RBL-  μâ“π¡–‡√Á߇¡Á¥‡≈◊Õ¥¢“« (P388) ‰¥â.
             2H3 °√–™“¬¥” (Kaempferia parviflora) ∑’Ë °—¥¥â«¬

             ·Õ≈°ÕŒÕ≈å· ¥ßªØ‘°‘√‘¬“°“√μàÕμâ“π‚√§¿Ÿ¡‘·æâ Ÿß∑’Ë ÿ¥  ª√– ‘∑∏‘¿“æ¢Õß ¡ÿπ‰æ√‰∑¬∑’Ë¡’μàÕ‚√§‡√‘¡™π‘¥∑’Ë 1
             ª√– ‘∑∏‘¿“æ¢Õß°“√μàÕμâ“π∑’ˇ°‘¥®“°°“√°√–μÿâπ¥â«¬·Õπ쑇®π  ∑—Èß„πÀ≈Õ¥∑¥≈Õß·≈–„π —μ«å∑¥≈Õß
                                                                                *                 †           ‡
             ∑”„Àâ¡’°“√ª≈¥ª≈àÕ¬  β-hexosaminidase ´÷Ëß„™â‡ªìπμ—«μ‘¥μ“¡  Vimolmas Lipipun , Masahiko Kurokawa , Rutt Suttisri ,
                                                                                                        §
             °“√∑”≈“¬·°√ππŸ„π‡´≈≈å  RBL-2H3  ‚¥¬¡’§à“ IC  ‡∑à“°—∫  Pagorn Taweechotipatr*, Pornpen Pramyothin , Masao
                                                    50
                                                                      ¶                †
             10.9 μg/ml μ“¡¡“¥â«¬ ‰æ≈ (Zingiber cassumunar) ∑’Ë  Hattori , Kimiyasu Shiraki
              °—¥¥â«¬·Õ≈°ÕŒÕ≈å  IC  = 12.9 μg/ml ·≈– ¢¡‘Èπ¢“« (Cur-  *¿“§«‘™“®ÿ≈™’««‘∑¬“ §≥–‡¿ —™»“ μ√å ®ÿÓ≈ß°√≥å¡À“«‘∑¬“≈—¬
                               50
                                                                †
             cuma mangga) ∑’Ë °—¥¥â«¬πÈ”‚¥¬¡’  IC  = 36.1 μg/ml  Department of Virology, Toyama Medical and Pharmaceutical
                                              50
             πÈ”¡—πÀÕ¡√–‡À¬®“°æ◊™∑—Èß 6 ™π‘¥ ‰¡à· ¥ßƒ∑∏‘Ï„π°“√μàÕ  University, 2630 Sugitani, Toyama 939-0194, Japan
                                                                ‡
             μâ“πÕ“°“√·æâ (IC  > 100 μg/ml) πÕ°®“°π’Ȭ—ß∑”°“√∑¥ Õ∫  ¿“§«‘™“惰…»“ μ√凿 —™ §≥–‡¿ —™»“ μ√å ®ÿÓ≈ß°√≥å¡À“«‘∑¬“≈—¬
                          50
                                                                §
              “√ °—¥À¬“∫∑’Ë¡’μàժؑ°‘√‘¬“¢Õ߇Õπ‰´¡å  β-hexosaminidase  ¿“§«‘™“‡¿ —™«‘∑¬“ §≥–‡¿ —™»“ μ√å ®ÿÓ≈ß°√≥å¡À“«‘∑¬“≈—¬
                                                                ¶
             ‡æ◊ËÕ‡°‘¥§«“¡™—¥‡®π«à“ “√ °—¥À¬“∫‡À≈à“π’ȉª¡’º≈μàÕ°“√  Institute of Natural Medicine, Toyama Medical and Pharmaceu-
             ∑”ß“π¢Õ߇Õπ‰´¡åÀ√◊Õ°“√‰ª∑”≈“¬·°√πŸ º≈®“°°“√»÷°…“   tical University, 2630 Sugitani, Toyama 939-0194, Japan
             æ∫«à“ “√ °—¥À¬“∫‰¡à¡’º≈μàÕ°“√∑”ß“π¢Õ߇Õπ‰´¡å β-hex-  Antiviral Research 2003;60(3):175-80.

             osaminidase °“√∑¥ Õ∫§√—Èßπ’ȇªìπ°“√ π—∫ πÿπ„Àâ‡ÀÁπ«à“   π” ¡ÿπ‰æ√‰∑¬®”π«π 20 ™π‘¥¡“ °—¥‡æ◊ËÕª√–‡¡‘πº≈
             ¿Ÿ¡‘ªí≠≠“‰∑¬∑’Ë¡’°“√„™âæ◊™„π«ß»å¢‘ß ‚¥¬‡©æ“–Õ¬à“߬‘Ëß  μàÕ°“√√—°…“‚√§‡√‘¡∑’ˇ°‘¥®“°‰«√— ™π‘¥∑’Ë 1 (HSV-1) „π
             °√–™“¬¥”·≈–‰æ≈„π°“√√—°…“Õ“°“√·æâ·≈–‚√§∑’ˇ°’ˬ«°—∫  ®”π«ππ’È¡’æ◊™‡æ’¬ß 11 ™π‘¥ ∑’Ë “¡“√∂¬—∫¬—Èß°“√ÕÕ°μÿà¡∑’Ë

             °“√·æâμà“ß Ê                                       ‡°‘¥®“°‡™◊ÈÕ  HSV-1 ‰¥â¡“°°«à“√âÕ¬≈– 50 ∑’˧«“¡‡¢â¡¢âπ 100
                                                                μg/ml ª√–¬ß§å (Aglaia odorata)  ¡–√ÿ¡ (Moringa oleifera)
             Õß§åª√–°Õ∫∑“߇§¡’·≈–§«“¡‡ªìπæ‘…μàÕ‡´≈≈å¢ÕßÀ≠â“     ·≈–√“ß·¥ß (Ventilago denticulate) ‡ªìπæ◊™„π°≈ÿà¡ 11 ™π‘¥

             ≈‘Èπߟ                                             ∑’Ë¡’ª√– ‘∑∏‘¿“æ„π°“√μàÕμâ“π thymidine kinase-deficient
              ÿπ—π∑å ™—¬π–°ÿ≈*, °¡≈«√√≥ Õπ—πμå*, ®‘𥓠·μâ¡∫√√®ß*,  HSV-1 ·≈– phosphonoacetate-resistant HSV-1 strains.
                      †
             æ√∑‘æ“ æ‘™“                                        ª√– ‘∑∏‘¿“æ¢Õß°“√√—°…“‡√‘¡∑’Ë∑”„À⇰‘¥‡™◊ÈÕ∫πº‘«Àπ—ߢÕß
             *¿“§«‘™“‡§¡’ §≥–«‘∑¬“»“ μ√å ¡À“«‘∑¬“≈—¬»√’π§√‘π∑√«‘‚√≤  ÀπŸæ∫«à“ “√ °—¥®“°¡–√ÿ¡¢π“¥ 750 ¡‘≈≈‘°√—¡/πÈ”Àπ—°μ—« 1
             †
              ∂“∫—π¡–‡√Áß·Ààß™“μ‘                               °‘‚≈°√—¡/«—π ¡’º≈Õ¬à“ß¡’π—¬ ”§—≠μàÕ°“√æ—≤π“μÿà¡·º≈∑’Ë
             «“√ “√¡À“«‘∑¬“≈—¬»√’π§√‘π∑√«‘‚√≤ 2553;2(3).        º‘«Àπ—ß πÕ°®“°π’Ȭ—߬◊¥√–¬–‡«≈“‡©≈’ˬ¢Õß°“√√Õ¥™’«‘μ·≈–
   77   78   79   80   81   82   83   84   85   86   87